BD Acquires Edwards Lifesciences' Critical Care Unit for $4.2B
Becton, Dickinson and Company (BDX: NYSE) acquires Edwards Lifesciences' (EW: NYSE) Critical Care product group for $4.2 billion in cash.
Stay updated with breaking news from Edwards Lifescience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Becton, Dickinson and Company (BDX: NYSE) acquires Edwards Lifesciences' (EW: NYSE) Critical Care product group for $4.2 billion in cash.
E*Trade Considers Kicking Meme-Stock Leader Keith Gill Off Platform Morgan Stanley's trading platform discusses concerns about possible manipulation in GameStop. Spotify Shares Jump on... -June 03, 2024 at 09:15 pm EDT - MarketScreener
E*Trade Considers Kicking Meme-Stock Leader Keith Gill Off Platform Morgan Stanley's trading platform discusses concerns about possible manipulation in GameStop. Spotify Shares Jump on... -June 03, 2024 at 05:16 pm EDT - MarketScreener
The APAC Transcatheter Aortic-Valve Replacement (TAVR) market is projected to grow significantly, with the market size expected to reach approximately USD 3.8 billion by 2033, up from USD 1.2 billion in 2023, reflecting a compound annual growth rate (CAGR) of 12.2% during the forecast period from 2024 to 2033. This...
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 EPS estimates for shares of Edwards Lifesciences in a research report issued to clients and investors on Friday, April 26th. Leerink Partnrs analyst M. Kratky now expects that the medical research company will earn $0.71 per share for […]